Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Despite recent advances in tumor imaging and chemoradiotherapy, the median overall survival of patients diagnosed with glioblastoma multiforme does not exceed 15 months. Infiltration of glioma cells into the brain parenchyma, and the blood-brain barrier are important hurdles to further increase the...

Full description

Bibliographic Details
Main Authors:	Stefaan W. van Gool, Steven de Vleeschouwer, Florence Lefranc, Véronique Mathieu, Rémi Rosière, Karim Amighi, Matthias van Woensel, Nathalie Wauthoz
Format:	Article
Language:	English
Published:	MDPI AG 2013-08-01
Series:	Cancers
Subjects:	glioblastoma multiforme intranasal administration nose-to-brain delivery formulations nanoparticles drug delivery new therapy concept
Online Access:	http://www.mdpi.com/2072-6694/5/3/1020

Similar Items

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
by: Ana Fortuna, et al.
Published: (2022-03-01)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
by: Tyler P. Crowe, et al.
Published: (2022-03-01)

Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug
by: Mohammed Ghazwani, et al.
Published: (2023-06-01)

Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?
by: Giovanna Rassu, et al.
Published: (2021-07-01)

Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route
by: Ahmad Ainurofiq, et al.
Published: (2023-05-01)

Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin
by: Toshihiko Tashima
Published: (2020-11-01)

Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders
by: Giovanna Rassu, et al.
Published: (2018-12-01)

Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
by: Soon-Seok Hong, et al.
Published: (2019-10-01)

Establishment of an Olfactory Region-specific Intranasal Delivery Technique in Mice to Target the Central Nervous System
by: Johannes Flamm, et al.
Published: (2022-01-01)

Factors involved in the design of nasal delivery systems for peptides and proteins
by: Adriana Muñoz-Cernada, et al.

Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs
by: Patrícia C. Pires, et al.
Published: (2022-03-01)

Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye
by: Ye Tao, et al.
Published: (2019-01-01)

Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
by: Matthias Van Woensel, et al.
Published: (2017-04-01)

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
by: Cláudia Pina Costa, et al.
Published: (2021-04-01)

Polymeric Nanoparticles as Oral and Intranasal Peptide Vaccine Delivery Systems: The Role of Shape and Conjugation
by: Prashamsa Koirala, et al.
Published: (2024-02-01)

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
by: Satya Siva Kishan Yalamarty, et al.
Published: (2023-04-01)

Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport
by: Shivam Singh, et al.
Published: (2023-09-01)

Formulation and Characterization of Intranasal Drug Delivery of Frovatriptan-Loaded Binary Ethosomes Gel for Brain Targeting
by: Hamzah ML, et al.
Published: (2024-01-01)

Intranasal Corticosteroids for the Medical Management of Nasal Polyps in Adults: a Meta-Analysis
by: Natividad A. Almazan-Aguilar
Published: (2007-11-01)

Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures
by: Alaa S. Tulbah, et al.
Published: (2023-12-01)

Intranasal 17β-Estradiol Modulates Spatial Learning and Memory in a Rat Model of Surgical Menopause
by: Alesia V. Prakapenka, et al.
Published: (2020-12-01)

The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route
by: Jiang Y, et al.
Published: (2019-11-01)

Clay Nanotubes Loaded with Diazepam or Xylazine Permeate the Brain through Intranasal Administration in Mice
by: Yaswanthi Yanamadala, et al.
Published: (2023-06-01)

Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications
by: Mariacristina Gagliardi, et al.
Published: (2023-04-01)

Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting
by: Elena Marcello, et al.
Published: (2023-02-01)

Recent progress in the intranasal PLGA-based drug delivery for neurodegenerative diseases treatment
by: Nasim Aghaei Delche, et al.
Published: (2023-10-01)

Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
by: Raquel Taléns-Visconti, et al.
Published: (2023-05-01)

The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses
by: Rémi Rosière, et al.
Published: (2019-03-01)

Evaluation of Ribavirin–Poloxamer Microparticles for Improved Intranasal Absorption
by: Dipy M. Vasa, et al.
Published: (2021-07-01)

Aerosolized In Vivo 3D Localization of Nose-to-Brain Nanocarrier Delivery Using Multimodality Neuroimaging in a Rat Model—Protocol Development
by: Michael C. Veronesi, et al.
Published: (2021-03-01)

The hidden obstacles to intranasal insulin delivery: A narrative review
by: Ujjawal Rawat, et al.
Published: (2023-01-01)

Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery
by: Maria Kannavou, et al.
Published: (2023-01-01)

Intranasal administration enhances size-dependent pulmonary phagocytic uptake of poly(lactic-co-glycolic acid) nanoparticles
by: Seung Ho Baek, et al.
Published: (2024-02-01)

Comparative pharmacokinetics of tetramethylpyrazine phosphate in rat plasma and extracellular fluid of brain after intranasal, intragastric and intravenous administration
by: Dongmei Meng, et al.
Published: (2014-02-01)

Intranasal Administration for Pain: Oxytocin and Other Polypeptides
by: Vimala N. Bharadwaj, et al.
Published: (2021-07-01)

Reversed phase HPLC determination of zidovudine in rat plasma and its pharmacokinetics after a single intranasal dose administration
by: RUBIANA M MAINARDES, et al.
Published: (2009-01-01)

Thermosensitive hydrogel designed for improving the antidepressant activities of genipin via intranasal delivery
by: Xue-Jie Qi, et al.
Published: (2021-08-01)

Intranasal Microemulsion as an Innovative and Promising Alternative to the Oral Route in Improving Stiripentol Brain Targeting
by: Sara Meirinho, et al.
Published: (2023-06-01)

Carotenoid containing cationic nanoparticles for effective therapy for suppressing oxidative stress: An intranasal approach
by: Namdev Dhas, et al.
Published: (2023-09-01)

Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
by: Laura Micheli, et al.
Published: (2020-09-01)